Yabro ® is a Class IIa medical device intended for the restoration and maintenance of the physiological conditions of the interstice and the pulmonary mucosa which have been impaired in chronic bronchial inflammation, for example in asthma and chronic obstructive pulmonary disease (COPD).Yabro ® is also indicated for the adjuvant treatment of upper respiratory disease such as tonsillitis, laryngitis, pharyngitis, nasopharyngitis, sinusitis, rhinitis, tracheitis, both in acute and chronic hoarseness, vocal cord inflammation with and without dysphonia; to improve post-operative conditions of the nasal mucosa after intranasal operations. Each Yabro ® vial to be administered by aerosol one per day contains 0.3% of hyaluronic acid sodium salt in 3 ml of an isotonic solution.
When YABRO ® is proposed for the treatment of upper respiratory disease, the solution can also be administered by using the innovative device YABRO ® Spray-sol.
YABRO ® Spray-sol enables an easy nebulization of YABRO ® solution into the nostril. It offers equal effectiveness of traditional nebulizers with the advantage of a more comfortable and practical use for the patient.